Stroke after cardiac surgery: A retrospective analysis of the effect of aprotinin dosing regimens

Annals of Thoracic Surgery

Volumn 75, Issue 2, 2003, Pages 479-483

  Frumento, Robert J ^a   O'Malley, Catherine M N ^a   Bennett Guerrero, Elliott ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; KALLIKREIN;

ADULT; AGE DISTRIBUTION; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; BLEEDING; CALCULATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART SURGERY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; KALLIKREIN KININ SYSTEM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; VALIDATION PROCESS;

AGED; APROTININ; CARDIAC SURGICAL PROCEDURES; CEREBROVASCULAR ACCIDENT; FEMALE; HEMOSTATICS; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SERINE PROTEINASE INHIBITORS;

EID: 0037312467     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04475-2     Document Type: Article

References (20)

1. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996;335:1857-63.
2. Wolman RL, Nussmeier NA, Aggarwal A, et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators. Stroke 1999;30:514-22.
3. Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth 1992;6:76-100.
4. Blauhut B, Gross C, Necek S, et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101:958-67.
5. Speekenbrink RG, Wildevuur CR, Sturk A, Eijsman L. Low-dose and high-dose aprotinin improve hemostasis in coronary operations. J Thorac Cardiovasc Surg 1996;112:523-30.
6. Levy JH. Hemostatic agents and their safety. J Cardiothorac Vasc Anesth 1999;13(Suppl 1):6-11, discussion 36-7.
7. Levy JH, Pifarre R, Schaff HV, et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995;92:2236-44.
8. Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen. Ann Thorac Surg 1996;62:1575-7.
9. Newman MF, Wolman R, Kanchuger M, et al. Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Circulation 1996;94(Suppl):II74-80.
10. van der Linden J, Hadjinikolaou L, Bergman P, Lindblom D. Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol 2001;38:131-5.
11. Engelman DT, Cohn LH, Rizzo RJ. Incidence and predictors of tias and strokes following coronary artery bypass grafting: report and collective review. Heart Surg Forum 1999;2:242-5.
12. Borger MA, Ivanov J, Weisel RD, et al. Stroke during coronary bypass surgery: principal role of cerebral macroemboli. Eur J Cardio-thorac Surg 2001;19:627-32.
13. del Zoppo GJ. Antithrombotic treatments in acute ischemic stroke. Curr Opin Hematol 2000;7:309-15.
14. Seghaye MC, Duchateau J, Grabitz RG, et al. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg 1996; 61:1205-11.
15. Ashraf S, Tian Y, Cowan D, et al. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg 1997;63:68-73.
16. Tassani P, Augustin N, Barankay A, et al. High-dose aprotinin modulates the balance between proinflammatory, and anti-inflammatory responses during coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000;14:682-6.
17. Gingrich MB, Traynelis SF. Serine proteases and brain damage - is there a link? Trends Neurosci 2000;23:399-407.
18. Poullis M, Manning R, Laffan M, et al. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg 2000;120:370-8.
19. Maquelin KN, Nieuwland R, Lentjes EG, et al. Aprotinin administration in the pericardial cavity does not prevent platelet activation. J Thorac Cardiovasc Surg 2000;120:552-7.
20. Ohyama H, Hosomi N, Takahashi T, et al. Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia. Brain Res 2001;902:264-71.